dextroamphetamine has been researched along with alpha-synuclein in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baekelandt, V; Männistö, PT; Myöhänen, TT; Patrikainen, S; Piltonen, M; Savolainen, M | 1 |
| Andersen, KJ; Febbraro, F; Romero-Ramos, M; Sanchez-Guajardo, V; Tentillier, N | 1 |
2 other study(ies) available for dextroamphetamine and alpha-synuclein
| Article | Year |
|---|---|
Comparison of motor performance, brain biochemistry and histology of two A30P α-synuclein transgenic mouse strains.
Topics: alpha-Synuclein; Animals; Behavior, Animal; Brain; Corpus Striatum; Dextroamphetamine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Gait; Mice; Mice, Transgenic; Motor Activity; Neurons | 2013 |
Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model.
Topics: Administration, Intranasal; alpha-Synuclein; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Cell Line, Transformed; Corpus Striatum; Deferoxamine; Dextroamphetamine; Disease Models, Animal; Female; Forelimb; Gene Expression Regulation; Genetic Vectors; Humans; Motor Activity; Nerve Tissue Proteins; Parkinson Disease; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Siderophores; Time Factors; Transfection; Tyrosine 3-Monooxygenase | 2013 |